How to build a stronger manufacturing strategy for oral solid dose (OSD)

Drug pipelines are evolving rapidly, with increasing focus on highly potent APIs, targeted therapies, and complex oral solid dose (OSD) formulations. As development complexity grows, manufacturing strategy has become a critical factor in bringing new medicines to market efficiently.

In this whitepaper, “Placing drug strategies on a solid foundation for success,” explore the industry trends influencing pharmaceutical outsourcing and commercial manufacturing decisions today.

Download the whitepaper to discover:

Key trends shaping pharmaceutical manufacturing and outsourcing strategies
Why complex compounds and highly potent APIs are influencing commercial manufacturing decisions
Considerations for scaling oral solid dose products from development to commercial supply
What drug developers should evaluate when selecting a contract manufacturing organization

Powered by Pfizer expertise, Pfizer CentreOne provides commercial manufacturing capabilities designed to help pharmaceutical companies navigate complex OSD requirements and support their drug commercialization strategies.

Download the whitepaper to gain insights that can help inform your manufacturing approach.

Pfizer CentreOne

Free Download

Fill out the form

Salutation First Name Last Name Email* Company Phone Department Position Street Zip City Country * Declaration of Consent

By completing this form to access the whitepaper, I understand my data will be shared with Pfizer CentreOne who may send me relevant updates and offers, and I can unsubscribe at any time via opt-out instructions in the emails. For more information on how your information will be used, please see the Privacy Policy.

Notes on data protection: Before receiving the white paper, you must register by providing your first and last name, your e-mail address, and possibly other data about yourself or your company. Please fill in the fields provided in the registration form.

Your data will be stored at B2B Expertise for the purpose of direct marketing and will be passed on to all affiliated companies of B2B Interactive GmbH as well as to our partner Pfizer CentreOne. For more information on the processing in our company, please refer to the B2B Interactive Privacy Policy.

You can revoke your consent at any time with effect for the future in writing by e-mail to the following address: info@b2binteractive.com (Subject: Pfizer CentreOne).